44 PRIMECAP Management Biogen Trades
PRIMECAP Management's position in Biogen is currently worth $3.57 Billion. That's 2.65% of their equity portfolio (6th largest holding). The investor owns 11.50% of the outstanding Biogen stock. The first Biogen trade was made in Q1 2013. Since then PRIMECAP Management bought shares eleven more times and sold shares on 32 occasions. The stake costed the investor $2.77 Billion, netting the investor a gain of 29% so far.
News about Biogen Inc and PRIMECAP Management
Should You Be Confident in Biogen (BIIB)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2024 investor letter. A copy of ...
Boston Common Asset Management LLC Boosts Holdings in Biogen Inc. (NASDAQ:BIIB)
Boston Common Asset Management LLC lifted its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 62.3% during the third quarter, according to its most recen...
Morningstar Investment Management LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB)
Morningstar Investment Management LLC purchased a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 2nd quarter, according to its most recen...
Biogen Inc. (BIIB) Management presents at Decentralized Clinical Trials in Focus Conference (Transcript)
Biogen Inc. (NASDAQ:NASDAQ:BIIB) Decentralized Clinical Trials in Focus Conference September 26, 2023 10:00 AM ETCompany ParticipantsStephanie Manson Brown -...